Brief: Singular Genomics Systems Q4 EPS USD -0.32
18/03/2024 20:05
Mar 18 (Reuters) - Singular Genomics Systems Q4 net income USD -23.249 million. * Q4 operating expenses USD 24.824 million * Q4 operating income USD -25.281 million
Recent news on Singular Genomics Systems
See all newsBrief: Singular Genomics Systems Inc Deerfield Increases Purchase Price To $24.00 Per Share
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Concentra Biosciences And Tang Capital
Singular Genomics up after Tang Capital offers to buy it
Brief: Tang Capital Management, Llc Reports 14.9% Stake In Singular Genomics Systems Inc As Of Sept 16 - SEC Filing
Brief: Singular Genomics Receives Non-Binding Acquisition Proposal From Deerfield